Suppliers / Dongbang Future Tech & Life Co, Ltd (1731)

Dongbang Future Tech & Life Co, Ltd (1731)

South Korea Updated 9 July 2026

Dongbang Future Tech & Life Co, Ltd (1731) is a finished-dose manufacturer based in South Korea. It appears in 206 regulatory filings across 7 regulators, without an active US DMF or CEP on file. Its filings concentrate with DH (HK), NMPA (CN) and EEC_EAEU. Its GMP standing is certified by EMA.

0
active US DMFs
0
valid CEPs
3
registered plants
206
filings across 7 regulators
These figures were checked against the regulators' own files on 25 July 2026
EU GMP
1 of 1 confirmed
Sources: EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Registered plants

Site FDA FEI
Qingdao, United Arab Emirates Not on file
Kyungki-Do, South Korea Not on file
Lordelo, Portugal Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
DH (HK) 158 None
NMPA (CN) 23 None
EEC_EAEU 19 None
EDA (EG) 3 None
MINSA (CR) 1 None
NPRA (MY) 1 None
EMA None 1

Comparing suppliers?

Choose your molecules and target markets. Dongbang Future Tech & Life Co, Ltd (1731) comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates